Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OR › Lincoln City › NPI 1306897491
Hospital

Samaritan North Lincoln Hospital

Samaritan North Lincoln Hospital was paid $12.27M by Medicaid between Jan 2018 and Nov 2024, across 62 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.

33Billing provider infoSAMARITAN NORTH LINCOLN HOSPITAL
LINCOLN CITY, OR 97367
33aNPI1306897491assigned 05/13/2006
33bProvider typeCritical Access Hospital
28Total paid$12.27M
24GClaims143,141
24DCodes billed62
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Critical Access Hospital providers in Oregon

Rank by total paid#8 of 22
Median peer was paid$3.52M
This provider vs. median3.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official OGDEN, LESLEY controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201817,906$1.30M
201917,866$1.33M
202016,353$1.24M
202122,764$1.80M
202224,325$1.94M
202323,116$2.25M
2024incomplete20,811$2.41M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 39% 25,020 16,504 $4.73M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 36% 15,427 9,885 $4.41M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.8% 9,904 7,178 $831K
80053 Comprehensive metabolic panel 3.1% 15,339 12,797 $383K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.8% 16,164 13,311 $339K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.0% 712 509 $245K
36415 Collection of venous blood by venipuncture 1.6% 24,040 20,140 $195K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.4% 2,697 2,267 $176K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 1,639 1,452 $132K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,249 2,849 $122K
81514 <1% 294 253 $85K
81001 <1% 5,153 4,489 $78K
50 more codes
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 942 $65K
96375 Therapeutic injection; each additional sequential IV push <1% 735 $45K
84443 Thyroid stimulating hormone (TSH) <1% 1,393 $40K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,248 $37K
84484 <1% 1,163 $36K
71045 Radiologic examination, chest; single view <1% 431 $29K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 3,262 $28K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 412 $24K
80061 Lipid panel <1% 1,035 $24K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 3,534 $18K
85610 <1% 1,343 $18K
83036 Hemoglobin; glycosylated (A1C) <1% 940 $17K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 843 $16K
83690 <1% 655 $15K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 262 $15K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 262 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 346 $13K
83605 <1% 618 $13K
83735 <1% 802 $12K
99214 Doctor's office visit, returning patient (more involved) <1% 346 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 40 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 12 $4K
71046 Radiologic examination, chest; 2 views <1% 27 $4K
88142 <1% 87 $4K
80306 <1% 57 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 132 $3K
83880 <1% 49 $3K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 31 $3K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 87 $3K
85730 <1% 146 $2K
85027 <1% 204 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 18 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 80 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 70 $2K
96367 <1% 46 $2K
J3490 Unclassified drugs <1% 77 $1K
A9270 Non-covered item or service <1% 1,414 $1K
87800 <1% 45 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 13 $1K
80048 Basic metabolic panel (calcium, ionized) <1% 53 $1K
82607 <1% 33 $988.67
0001A <1% 36 $919.20
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 14 $882.00
82803 <1% 21 $826.14
82746 <1% 12 $705.60
0011A <1% 22 $638.40
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 17 $577.00
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 30 $540.96
91300 0% 36 $0.00
91301 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialOGDEN, LESLEY (CEO-SNLH)
Same official

Other billing entities under OGDEN, LESLEY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.